-
EXCLUSIVE: Beeline Closes Its First Crypto Real Estate Transaction
2025 Jun 25, 8:00am | 448Beeline Holdings (NASDAQ:BLNE) announced Wednesday that its subsidiary, Beeline Title Holdings ("Beeline Title"), has closed one of the first-ever residential real estate transactions funded through the sale of a cryptocurrency token backed by real property. Nick Liuzza, CEO of Beeline Holdings,...
-
Will Bitcoin Hit New All-Time Highs After Dip Under $100K? Here's What New Poll Predicts
2025 Jun 23, 10:43am | 643Tensions in the Middle East have caused the price of Bitcoin (CRYPTO: BTC) to go down by under $100,000 in the last several days. A Benzinga reader poll may have predicted that move and could show what happens next. What Happened: The leading cryptocurrency, Bitcoin, continues to see increased...
-
EXCLUSIVE: Worksport Clocks $1.3 Million Revenue In May, Margins Rise
2025 Jun 23, 8:20am | 383Worksport (NASDAQ:WKSP) announced on Monday that its May 2025 sales reached $1.28 million, marking its second consecutive month of record-breaking revenue (non-audited). Gross margins improved as Worksport’s Made-in-USA cover line gained significant traction, the company said....
-
EXCLUSIVE: Guardforce AI Renews 3-Year Deal With Thailand's Government Savings Bank
2025 Jun 23, 7:45am | 314Guardforce AI Co (NASDAQ:GFAI) on Monday announced that its subsidiary, Guardforce Cash Solutions Security (Thailand) Company Limited (GFCS), has won a three-year renewal with Government Savings Bank (GSB). GSB one of Thailand’s state-owned banks adn the renewal deal is effective from June 1...
-
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
2025 Jun 22, 9:10am | 1535Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods...
-
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
2025 Jun 18, 9:00am | 583Telomir Pharmaceuticals Inc. (NASDAQ:TELO) on Wednesday announced new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation. In this study, conducted by Smart Assays, Telomir-1 was tested in...
-
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout
2025 Jun 18, 8:03am | 462Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales operations, including its land clearing and green waste processing sites. Managed Waste Service is an...
-
EXCLUSIVE: Apple's Growth Engine Appears Stalled - Is It Time To Swap iPhones For Dividends?
2025 Jun 17, 1:46pm | 439Apple Inc. (NASDAQ:AAPL) has been logging a majority of revenue declines over the past few quarters – unusual for a company long viewed as a flagship growth stock. But for investors still expecting explosive upside from Cupertino, it may be time for a portfolio recalibration. Despite the...
-
Trump Wants Babies To Get $1,000 To Invest At Birth: This Magnificent 7 Stock Tops Poll For 18-Year Growth
2025 Jun 17, 9:50am | 775President Donald Trump has proposed giving parents $1,000 to invest for their children at birth. A Benzinga reader poll asks which of the Magnificent 7 stocks parents should consider buying and holding for 18 years under the new plan. What Happened: Trump's plan for $1,000 investment accounts for...
-
Coinfund President On AI Tokens, DePIN, And Why Clear Rules Will Unleash Next Wave Of Crypto Adoption
2025 Jun 16, 3:48pm | 755Christopher Perkins, President of CoinFund and a former Wall Street executive, believes the next chapter of crypto adoption hinges on clarity—regulatory, technological, and strategic. In an interview with Benzinga, Perkins discussed everything from AI-powered networks to staking yields, tokenized...
-
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
2025 Jun 14, 9:01am | 1508Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With...
-
EXCLUSIVE: S&P 500 To Hit New All-Time Highs Again In 2025? Majority Say Yes, 27% Predict This Range
2025 Jun 13, 2:16pm | 615The SPDR S&P 500 ETF Trust (NYSE:SPY) slipped Friday amid rising tensions between Israel and Iran, but Benzinga readers remain bullish, predicting new all-time highs later this year. What Happened: The SPDR S&P 500 ETF Trust reached 57 new all-time highs in 2024 and several so far in 2025,...
-
EXCLUSIVE: Toppoint Signs MoU With Peru's Chancay Municipality To Overhaul Waste Management
2025 Jun 11, 8:30am | 441Toppoint Holdings Inc. (NYSE:TOPP) on Wednesday announced that it has signed a memorandum of understanding with the Municipalidad Distrital de Chancay in Peru, marking the beginning of a collaboration to overhaul the area’s waste management system. The financial terms of the MoU were not...
-
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
2025 Jun 11, 8:01am | 518Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an update on its growing footprint in the U.S. Forensic Use Only Market on Wednesday through its strategic partnership with SMARTOX. SMARTOX, founded in 2012, is a U.S.-based provider of drug and alcohol testing products and services. It offers...
-
EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial
2025 Jun 11, 7:30am | 533Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Wednesday announced progress in the design and planning of its upcoming Phase 3 trial evaluating AD04, the company's lead investigational genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for Alcohol Use Disorder (AUD) in heavy...